Journal article
Cost-effectiveness of adoption strategies for point of care HIV viral load monitoring in South Africa
- Abstract:
-
Background
Viral load (VL) testing is recommended for monitoring people on ART. The National Health Laboratory Service (NHLS) in South Africa conducts >5million laboratory-based VL tests but faces challenges with specimen integrity and results delivery. Point-of-care (POC) VL monitoring may improve VL suppression (VLS). We assessed the cost-effectiveness of different strategies for POC testing in South Africa.
Methods
We developed a cost-outcome model utilizing NHLS data, including facility-level annual VL volumes, proportion with VLS, specimen rejection rates, turn-around-time, and the cost/test. We assessed the impact of adopting POC VL technology under 4 strategies: (1) status-quo; (2) targeted POC testing at facilities with high levels of viral failure; (3) targeted POC testing at low-performing facilities; (4) complete POC adoption. For each strategy, we determined the total cost, effectiveness (expected number of virally suppressed people) and incremental cost-effectiveness ratio (ICER) based on expected (>10%) VLS improvement.
Findings
Existing laboratory-based VL testing costs $126 m annually and achieves 85.2% VLS. Strategy 2 was the most cost-effective approach, with 88.5% VLS and $40/additional person suppressed, compared to the status-quo. Should resources allow, complete POC adoption may be cost-effective (ICER: $136/additional person suppressed), requiring an additional $49 m annually and achieving 94.5% VLS. All other strategies were dominated in the incremental analysis.
Interpretation
Assuming POC VL monitoring confers clinical benefits, the most cost-effective strategy for POC adoption in South Africa is a targeted approach with POC VL technologies placed at facilities with high level of viral failure.
Funding
Funding support from the Bill & Melinda Gates Foundation.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 862.5KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.eclinm.2020.100607
Authors
- Publisher:
- Elsevier
- Journal:
- EClinicalMedicine More from this journal
- Volume:
- 28
- Article number:
- 100607
- Publication date:
- 2020-11-04
- Acceptance date:
- 2020-10-08
- DOI:
- ISSN:
-
2589-5370
- Language:
-
English
- Keywords:
- Pubs id:
-
1136691
- Local pid:
-
pubs:1136691
- Deposit date:
-
2020-11-06
- ARK identifier:
Terms of use
- Copyright holder:
- Girdwood et al.
- Copyright date:
- 2020
- Rights statement:
- ©2020 The Author(s). Published by Elsevier Ltd.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record